SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001513162-21-000157
Filing Date
2021-12-15
Accepted
2021-12-15 12:52:04
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D sc13d.htm SC 13D 93875
  Complete submission text file 0001513162-21-000157.txt   95462
Mailing Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339
Business Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339 678-392-3419
Inhibikase Therapeutics, Inc. (Subject) CIK: 0001750149 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-92155 | Film No.: 211493691
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address ONE NEXUS WAY, CAMANA BAY SUITE 5B201, 2ND FLOOR GRAND CAYMAN E9 KY1-1108
Business Address ONE NEXUS WAY, CAMANA BAY SUITE 5B201, 2ND FLOOR GRAND CAYMAN E9 KY1-1108 0041433222510
FiveT Investment Management Ltd (Filed by) CIK: 0001846823 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D